🇺🇸 FDA
Pipeline program

SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine

LVRNA012-IIT-04

Unknown mab active

Quick answer

SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine for SARS-CoV-2 is a Unknown program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
SARS-CoV-2
Phase
Unknown
Modality
mab
Status
active

Clinical trials